Sarepta Therapeutics Launches ELEVIDYS in Japan for Duchenne Muscular Dystrophy

Sarepta Therapeutics Expands Access to Gene Therapy for Duchenne in Japan Is the future of gene therapy for rare diseases finally within reach? Sarepta Therapeutics, Inc. a leader in precision genetic medicine for rare diseases, has announced the commercial launch…









